Kenneth R. Deans Jr.
South Carolina
Kenneth R. Deans Jr. is a Contributing Writer for The American Quorum. With 30+ years of leadership across healthcare, technology, and education, he brings an experienced, independent perspective to issues shaping America.
Tech
Netflix Adds 2.4 Million Subscribers, Reversing Losses as $6.99 Ad Tier Nears Launch
Healthcare
FDA and CDC Expand Omicron-Targeted COVID Boosters to Children as Young as 5
Tech
Meta Unveils $1,499 Quest Pro With Full-Color Mixed Reality, Eye Tracking and Microsoft Work Tools
Healthcare
Flu Activity Starts Rising Early as CDC Finds 2.5% Test Positivity and Influenza A Dominates U.S. Surveillance
Tech
Musk Revives $44 Billion Twitter Deal at $54.20 a Share as Delaware Court Pauses Trial Until October 28
Healthcare
FDA Approves Relyvrio for ALS After 137-Patient Trial and Divided Review, Adding First New U.S. Treatment Since 2017
Tech
Google Will Shut Down Stadia in January and Refund Hardware and Games After Cloud Service Misses User Targets
Healthcare
Biden Says ‘Pandemic Is Over’ as Federal COVID Emergency, 400 Daily Deaths and Fall Booster Campaign Continue
Tech
Nvidia Unveils RTX 40 Series With $1,599 Flagship and DLSS 3 AI Frame Generation on New Ada Lovelace Architecture
Healthcare
U.S. Confirms Circulating Vaccine-Derived Poliovirus in New York as Wastewater Evidence Shows Community Transmission
Tech
Ethereum Completes ‘Merge,’ Cutting Network Energy Use About 99.95% as Proof-of-Stake Replaces Mining
Healthcare
Updated COVID-19 Boosters Begin U.S. Rollout, Targeting BA.4 and BA.5 as CDC Replaces Prior Booster Guidance
Tech
Apple Unveils iPhone 14 Lineup With Satellite SOS, 48-Megapixel Pro Camera and U.S. Shift to eSIM
Healthcare
FDA Authorizes BA.4/BA.5 Bivalent COVID-19 Boosters; CDC Recommends Updated Shots for Ages 12 and Older
Tech
U.S. Imposes China Export Licenses on Nvidia A100 and H100 AI Chips, Putting $400 Million in Quarterly Sales at Risk
Healthcare
Pfizer and Moderna Seek FDA Clearance for BA.4/BA.5 Bivalent COVID-19 Boosters Ahead of Fall Campaign
Tech
Twitter Whistleblower Alleges ‘Egregious’ Security Failures and Misleading Statements to Regulators
423 stories